Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Oncology, Odense University Hospital, Odense, Denmark

2 abstracts

Abstract
Overall survival following heterogeneous FDG-guided dose-escalation for locally advanced NSCLC in the international phase III NARLAL2 trial.
Org: Department of Oncology, Odense University Hospital, Odense, Denmark, Vejle Hospital, Vejle, Denmark, Aarhus University Hospital, Aarhus, Denmark, Odense University Hospital, Odense, Denmark, Odense University Hospital, Odense C, Denmark,
Abstract
Prognostic factors for relapse in patients with clinical stage I testicular seminoma: A nationwide, population-based cohort study.
Org: Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, Department of Pathology, Copenhagen University Hospital, Herlev Gentofte Hospital, Herlev, Denmark, Department of Pathology, Odense University Hospital, Odense, Denmark, Aarhus University Hospital, Aarhus, Denmark,